bpc-157 injection site near injury vs systemic Musculoskeletal and Tissue Healing with BPC 157: Weight Loss and Vitality: Medical Weight Loss Peptide for study Watch me get my Color:Pink Silk

bpc-157 injection site near injury vs systemic Musculoskeletal and Tissue Healing with BPC 157: Weight Loss and Vitality: Medical Weight Loss Peptide for study Watch me get my Color:Pink Silk

Watch me get my B12 injection 💫, 𝒯𝒽𝒶𝓃𝓀 𝓎𝑜𝓊 𝒩𝓊𝓇𝓈𝑒 𝒦𝒶𝓉𝑒 𝒻𝑜𝓇 𝒹𝑜𝒾𝓃𝑔 𝓂𝓎 𝒷𝟣𝟤 𝒾𝓃𝒿𝑒𝒸𝓉𝒾𝑜𝓃 , •𝙒𝙝𝙖𝙩 𝙙𝙤 𝙩𝙝𝙚𝙨𝙚 𝙝𝙚𝙡𝙥 𝙢𝙚 𝙬𝙞𝙩𝙝?, 𝘛𝘩𝘦𝘺 𝘤𝘢𝘯 𝘣𝘰𝘰𝘴𝘵 𝘦𝘯𝘦𝘳𝘨𝘺 𝘭𝘦𝘷𝘦𝘭𝘴, 𝘪𝘮𝘱𝘳𝘰𝘷𝘦 𝘴𝘭𝘦𝘦𝘱 𝘲𝘶𝘢𝘭𝘪𝘵𝘺, 𝘪𝘮𝘱𝘳𝘰𝘷𝘦 𝘤𝘰𝘨𝘯𝘪𝘵𝘪𝘷𝘦 𝘧𝘶𝘯𝘤𝘵𝘪𝘰𝘯, ...

Side-by-Side Comparison Feature Structure Melanotan 2 Cyclic 7-amino acid peptide Afamelanotide (MT-I) Linear 13-amino acid peptide PT-141 (Bremelanotide) Cyclic 7-amino acid derivative Feature Receptor focus Melanotan 2 MC1R + MC3R + MC4R + MC5R (non-selective) Afamelanotide (MT-I) MC1R-preferring PT-141 (Bremelanotide) MC3R/MC4R-preferring Feature Plasma half-life Melanotan 2 ~1-2 hours Afamelanotide (MT-I) ~0.8-1.7 hours PT-141 (Bremelanotide) ~2.7 hours Feature Main effect Melanotan 2 Tanning + sexual + appetite changes Afamelanotide (MT-I) Tanning and photoprotection PT-141 (Bremelanotide) Sexual arousal and desire Feature Tanning strength Melanotan 2 Strong Afamelanotide (MT-I) Strong PT-141 (Bremelanotide) Minimal Feature Sexual effect Melanotan 2 Strong in ED studies Afamelanotide (MT-I) Not primary PT-141 (Bremelanotide) Primary use case Feature Dosing Melanotan 2 Daily loading, then 1-2x weekly Afamelanotide (MT-I) Subcutaneous implant PT-141 (Bremelanotide) On-demand, max 1 per 24 hours Feature FDA status Melanotan 2 Not approved Afamelanotide (MT-I) Approved (Scenesse) for EPP PT-141 (Bremelanotide) Approved (Vyleesi) for low female sexual desire Feature Nausea burden Melanotan 2 High and dose-limiting Afamelanotide (MT-I) Lower in selective use PT-141 (Bremelanotide) Common, listed on label These three compounds share melanocortin ancestry, but they are not interchangeable

Peptide for study

Color:Pink Silk

Close up